Covered recipient · General Payments record
DIANA E MOLLER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,849.99
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $911.79 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $386.52 | 18 |
| Phathom Pharmaceuticals, Inc. | $149.99 | 1 |
| Amgen Inc. | $93.85 | 4 |
| Ardelyx, Inc. | $74.02 | 3 |
| IRONWOOD PHARMACEUTICALS, INC | $49.98 | 2 |
| Acerta Pharma LLC | $35.92 | 2 |
| PFIZER INC. | $27.20 | 1 |
| CeQur Corporation | $26.24 | 1 |
| Lilly USA, LLC | $26.18 | 1 |
| Novo Nordisk AS | $22.63 | 1 |
| Fresenius USA Marketing, Inc. | $19.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.82 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679389 | CMS |
| ABBVIE INC. | $23.71 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679391 | CMS |
| ABBVIE INC. | $17.45 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679393 | CMS |
| ABBVIE INC. | $2.72 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679395 | CMS |
| ABBVIE INC. | $26.37 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679397 | CMS |
| ABBVIE INC. | $27.08 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679399 | CMS |
| ABBVIE INC. | $11.41 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679401 | CMS |
| ABBVIE INC. | $18.52 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679403 | CMS |
| ABBVIE INC. | $24.98 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679405 | CMS |
| ABBVIE INC. | $11.87 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679407 | CMS |
| ABBVIE INC. | $23.01 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679409 | CMS |
| ABBVIE INC. | $27.14 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679411 | CMS |
| ABBVIE INC. | $23.38 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679413 | CMS |
| ABBVIE INC. | $24.16 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679415 | CMS |
| ABBVIE INC. | $23.08 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679417 | CMS |
| ABBVIE INC. | $27.50 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679419 | CMS |
| ABBVIE INC. | $27.88 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679421 | CMS |
| ABBVIE INC. | $13.44 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107679423 | CMS |
| Amgen Inc. | $24.17 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117632375 | CMS |
| Amgen Inc. | $21.56 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115940218 | CMS |
| Amgen Inc. | $28.74 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115940212 | CMS |
| Amgen Inc. | $19.38 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117632377 | CMS |
| Ardelyx, Inc. | $23.47 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146738078 | CMS |
| Ardelyx, Inc. | $26.64 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146738080 | CMS |
| Ardelyx, Inc. | $23.91 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146738082 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.09 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105647016 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.83 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104564370 | CMS |
| CeQur Corporation | $26.24 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099649691 | CMS |
| Fresenius USA Marketing, Inc. | $19.26 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154193054 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $24.27 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153758030 | CMS |
| IRONWOOD PHARMACEUTICALS, INC | $25.71 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153770596 | CMS |
| Lilly USA, LLC | $26.18 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135629979 | CMS |
| Novo Nordisk Inc | $22.63 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100570066 | CMS |
| PFIZER INC. | $27.20 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131968981 | CMS |
| Phathom Pharmaceuticals, Inc. | $149.99 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151190272 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.